Massmutual Trust Co. FSB ADV Raises Position in CME Group Inc. (NASDAQ:CME)

Massmutual Trust Co. FSB ADV boosted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 161.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,600 shares of the financial services provider’s stock after acquiring an additional 6,542 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in CME Group were worth $2,084,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Second Half Financial Partners LLC purchased a new position in CME Group in the 4th quarter worth approximately $2,737,000. Sapient Capital LLC bought a new position in CME Group in the 4th quarter worth $1,823,000. Raymond James Financial Services Advisors Inc. boosted its holdings in CME Group by 2.3% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,041,526 shares of the financial services provider’s stock worth $224,230,000 after buying an additional 23,340 shares during the period. Bluefin Capital Management LLC bought a new position in shares of CME Group during the 4th quarter valued at about $2,891,000. Finally, Alaska Permanent Fund Corp boosted its holdings in shares of CME Group by 81.4% during the 1st quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock valued at $9,588,000 after purchasing an additional 19,985 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other news, Director Elizabeth A. Cook sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $211.52, for a total value of $211,520.00. Following the sale, the director now directly owns 18,241 shares of the company’s stock, valued at approximately $3,858,336.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Terry L. Savage sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $210.65, for a total transaction of $526,625.00. Following the sale, the director now directly owns 17,441 shares of the company’s stock, valued at approximately $3,673,946.65. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Elizabeth A. Cook sold 1,000 shares of the stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $211.52, for a total transaction of $211,520.00. Following the completion of the sale, the director now directly owns 18,241 shares in the company, valued at $3,858,336.32. The disclosure for this sale can be found here. Insiders have sold 14,290 shares of company stock worth $2,957,300 in the last ninety days. 0.30% of the stock is owned by insiders.

CME Group Stock Performance

CME traded down $2.61 on Monday, reaching $197.22. The stock had a trading volume of 2,133,193 shares, compared to its average volume of 1,960,977. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The business’s 50-day moving average price is $198.38 and its two-hundred day moving average price is $207.01. The company has a market cap of $71.01 billion, a P/E ratio of 22.86, a price-to-earnings-growth ratio of 6.27 and a beta of 0.52.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.30 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 9.8 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.33%. CME Group’s payout ratio is presently 52.33%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CME shares. Morgan Stanley increased their price target on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Tuesday, April 9th. Barclays raised their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Rosenblatt Securities reiterated a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of CME Group from $195.00 to $193.00 and set a “hold” rating for the company in a research note on Thursday, July 25th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $212.64.

Get Our Latest Report on CME Group

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.